Search results
Results from the WOW.Com Content Network
Ethylene glycol (IUPAC name: ethane-1,2-diol) is an organic compound (a vicinal diol [7]) with the formula (CH 2 OH) 2. It is mainly used for two purposes: as a raw material in the manufacture of polyester fibers and for antifreeze formulations. It is an odorless, colorless, flammable, viscous liquid.
The recommendation came from a study conducted by the British Medical Research Council (MRC) Vitamin Study Group from July 1983 to April 1991 involving 33 centers (17 of which in the UK and the remaining 16 in 6 different countries) that compared pregnancy outcomes of folic acid and other vitamins interventions with placebo. That study found a ...
Ethane-1,2-dithiol, also known as EDT, [1] is a colorless liquid with the formula C 2 H 4 2. It has a very characteristic odor which is compared by many people to rotten cabbage . It is a common building block in organic synthesis and an excellent ligand for metal ions.
Glycol ethers are designated "E-series" or "P-series" for those made from ethylene oxide or propylene oxide, respectively.Typically, E-series glycol ethers are found in pharmaceuticals, sunscreens, cosmetics, inks, dyes and water-based paints, while P-series glycol ethers are used in degreasers, cleaners, aerosol paints and adhesives.
That is approximately 224 mL (7.6 oz.) of 50% ethylene glycol for an 80 kg adult and 56 mL (2 oz.) for a 20 kg child. Although survival with medical treatment has occurred with doses much higher than this, death has occurred with 30 mL of the concentrate in an adult.
Ethylene glycol dimethylacrylate (EGDMA) is a diester formed by condensation of two equivalents of methacrylic acid and one equivalent of ethylene glycol. [2]EGDMA can be used in free radical copolymer crosslinking reactions.
A 2014 study found no significant differences between men and women, and between non-pregnant and pregnant individuals, despite the existence of anecdotal reports of hyperosmia among the latter. [7] People with Multiple Sclerosis have been found to have higher olfactory thresholds.
At 48 weeks, 55% of participants receiving maraviroc once daily and 60% of participants receiving the drug twice daily achieved a viral load of less than 400 copies/mL compared with 26% of those taking placebo; about 44% of the once-daily and 45% of the twice-daily maraviroc group had a viral load of less than 50 copies/mL compared with about ...